Dr Benjamin Wakerley PhD FRCP

Dr Benjamin Wakerley

Department of Metabolism and Systems Science
Honorary Clinical Associate Professor
Consultant Neurologist
Director of Birmingham Headache Centre

Contact details

Address
Metabolic Neurology
ºÚÁϳԹÏÍø
Edgbaston
Birmingham
B15 2TT
UK

Dr Wakerley is a leading Consultant Neurologist and expert in headache. He is also an Honorary Clinical Associate Professor at the Department of Metabolism and Systems Science (MSS).

Qualifications

  • FRCP, Royal College of Physicians, London, 2019
  • MRCP (Neurology), Royal College of Physicians, London, 2012
  • PhD in Molecular Immunology, Imperial College, London, 2009
  • MRCP, Royal College of Physicians, London, 2003
  • MBBS, Imperial College School of Medicine, London, 2001
  • BSc in Neuroscience (1st class), University College London, London, 1997

Biography

Dr Wakerley completed a BSc in Neuroscience at University College London in 1997 before graduating from Imperial College School of Medicine in 2001. He attained MRCP in 2003 and in 2009 completed his PhD in molecular immunology which was funded by an MRC clinical training fellowship.

He completed his neurology registrar training in Oxford and Singapore before being appointed a consultant in 2014.

He now leads the tertiary referral complex headache service at University Hospitals Birmingham and is actively involved in research at the ºÚÁϳԹÏÍø within Metabolic and Systems Science.

Teaching

Dr Wakerley regularly teaches on headache to acute physicians, neurology trainees, consultants and general practitioners. He has also given lectures nationally and internationally on headache.

Postgraduate supervision

2022-2024 - Katherine Phillips, ºÚÁϳԹÏÍø - PhD (completed) - Interplay between migraine and pregnancy outcomes.

  1. 2024-present - Charley Ellis, University of Reading - PhD (in progress) - Enhancing Migraine Management through Psychological Interventions: A Multi-Phase Study on Effectiveness and Accessibility.

Research

Dr Wakerley’s main research interests include:

  1. Medication-overuse headache
  2. Migraine and pregnancy
  3. Psychological aspects of chronic migraine

If you are interested in doing a PhD with Dr Wakerley on headache – then please email b.wakerley@bham.ac.uk.

Other activities

Membership of professional bodies

  • GMC 6028684
  • Royal College of Physicians
  • Association of British Neurologists

Clubs and societies

  • Oxford Symposium on Headache - organiser (2014 - present
  • British Association for the Study of Headache (BASH) – Education Officer (2022 – present)
  • The Midland Neuroscience Teaching and Research Fund - Board of Trustees (2025 - present)
  • Southwest of England Neurosciences Association - Treasurer (2019 - present)

Public Engagement

  • Dr Wakerley has given several talks for the Migraine Trust –

 

 

  • Founder of Neuroscience, Education and Research on Medication-Overuse Headache (NEMO) – a group for patients with medication-overuse headache

Patents and commercialisation

  • Founder of Ceftronics Limited and the CEFREF - Migraine mobile application

  • GB2584130 (granted 2022), GB2601091 (granted 2023), EP3972486 (granted 2024) - Wearable device for recording headache intensity and medication

Publications

  1.   Network meta analysis comparing efficacy of different strategies on medication overuse headache. Koonalintip P, Yamutai S, Setthawatcharawanich S, Thongseiratch T, Chichareon P, Wakerley BR. J Headache Pain. 2025 Apr 16;26(1):81. doi: 10.1186/s10194-025-02031-1. PMID: 402409.
  2. CGRP therapy in primary care for migraine: prevention and acute medication. Phillips K, Wakerley BR. Br J Gen Pract. 2024 Oct 31;74(748):521-522. doi: 10.3399/bjgp24X739893. Print 2024 Nov. PMID: 3948190.
  3. Patient-completed online "follow-up form" to assess continuation of anti-CGRP(r) antibody therapy in patients with chronic migraine: A pilot project. Stuart S, Gregg S, Ware S, Koonalintip P, Wakerley BR. Clin Neurol Neurosurg. 2024 Dec;247:108594. doi: 10.1016/j.clineuro.2024.108594. Epub 2024 Oct 24. PMID: 3948134.
  4. Migraine and Pregnancy. Phillips K, Koonalintip P, Wakerley BR. Life (Basel). 2024 Sep 25;14(10):1224. doi: 10.3390/life14101224.PMID: 39459524.
  5. Medication-Overuse Headache: Update on Management. Koonalintip P, Phillips K, Wakerley BR. Life (Basel). 2024 Sep 11;14(9):1146. doi: 10.3390/life14091146. PMID: 39337929.
  6. Trends in the prevalence and pharmacological management of migraine during pregnancy in the UK, 2000-2018. Phillips K, Nirantharakumar K, Wakerley BR, Crowe FL. J Neurol Neurosurg Psychiatry. 2024 Sep 17;95(10):938-946. doi: 10.1136/jnnp-2024-333530. PMID: 38569874.
  7. How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis. Phillips K, Clerkin-Oliver C, Nirantharakumar K, Crowe FL, Wakerley BR. Cephalalgia. 2024 Feb;44(2):3331024241229410. doi: 10.1177/03331024241229410. PMID: 38317644.
  8. Headache in pregnancy: a brief practical guide.Phillips K, Davison J, Wakerley B. Br J Gen Pract. 2022 Nov 24;72(725):593-594. doi: 10.3399/bjgp22X721457. Print 2022 Dec.PMID: 3642416.
  9. Idiopathic intracranial hypertension: Evaluation of births and fertility through the Hospital Episode Statistics dataset. Thaller M, Mytton J, Wakerley BR, Mollan SP, Sinclair AJ. BJOG. 2022 Nov;129(12):2019-2027. doi: 10.1111/1471-0528.17241. Epub 2022 Jun 21. PMID: 35620863.
  10. Managing idiopathic intracranial hypertension in pregnancy: practical advice. Thaller M, Wakerley BR, Abbott S, Tahrani AA, Mollan SP, Sinclair AJ. Pract Neurol. 2022 Aug;22(4):295-300. doi: 10.1136/practneurol-2021-003152. Epub 2022 Apr 21. PMID: 35450962.

Links to publications